Chlamydia Diagnosis Market: Global Market Size and Forecast 2018-2023

Posted by pranshu@95 on August 6th, 2019

According to OMR analysis, the Global Chlamydia Diagnosis Market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The change in lifestyle especially related to sex preferences is the major factor driving the growth of this market, moreover, the increase in the use of rapid point of care diagnosis kits also propels the market. The treatment of this disease is prolonged and usually achieved by administration of oral antibiotics to the patients.

Furthermore, the global chlamydia diagnosis market is segmented on the basis of diagnosis methods, treatment approach, and end-user. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

A full report of global Chlamydia diagnosis market is available at : https://www.omrglobal.com/industry-reports/chlamydia-disease-diagnosis-treatment-market/

Market Segmentation

1. Global Chlamydia Market by Diagnosis Methods

• Chlamydia Culture
• Urine Culture
• Enzyme Immunoassays
• Nucleic Acid Amplification Test

2. Global Chlamydia Market by Treatment Approach

• Oral Antibiotics

3. Global Chlamydia Diagnosis and Treatment Market by End-User

• Hospitals
• Diagnostic Centers
• Research Institutions

Region Covered

• North America (the US and Canada)
• Europe (the United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, Japan, and South Korea)
• Rest of the World  (the Middle East & Africa and Latin America)

Company Profiled

• Abbott Laboratories, Inc.
• Aetna, Inc.
• Agilent Technologies
• Akers Biosciences, Inc.
• Bio-Rad Laboratories, Inc.
• Cigna
• Clinical Lab Product
• Diadexus, Inc.
• Erba Diagnostics
• Hologic, Inc.
• Laboratory Corporation Of America
• Novartis Diagnostics
• Qiagen
• Quidel Corp.
• Roche Molecular Systems, Inc.
• Siemens AG
• Synapse Diagnostics
• Sysmex Corp.
• Thermo Fisher Scientific
• Tosoh Corp.

The key objectives of the Chlamydia Diagnosis Market study:

• To analyze the Chlamydia Diagnosis Market by segments with historical data of 2017 and 2018 and forecast to 2025.
• To study the key factors influencing the growth of the market.
• Focuses on the key leaders to define and analyze the sales volume, value, share, competitive landscapes, SWOT analysis, and development plans.
• To analyze the Chlamydia Diagnosis Market growth, global trends, future prospectus and contribution to the market.

Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667,+91 780-304-0404